NASDAQ:HEPA

Hepion Pharmaceuticals Stock Insider Trading

etoro logo Buy HEPA
*Your capital is at risk
$0.0600
-0.0030 (-4.76%)
At Close: Jun 03, 2026

Hepion Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 21.86M and sold 0 HEPA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 21.86M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Aug 19, 2020
Buy
Stock Options
A-Award
Jacob Gary S
Director
Director 30 000
Value: $111.6K
Aug 19, 2020
Buy
Stock Options
A-Award
Brancaccio John P
Director
Director 30 000
Value: $111.6K
Aug 19, 2020
Buy
Stock Options
A-Award
Adams Thomas Phd
Director
Director 30 000
Value: $111.6K
Aug 19, 2020
Buy
Stock Options
A-Award
Block Timothy M.
Director
Director 30 000
Value: $111.6K
Aug 19, 2020
Buy
Stock Options
A-Award
Lippa Arnold
Director
Director 30 000
Value: $111.6K
Aug 19, 2020
Buy
Stock Options
A-Award
Foster Robert T
CEO,cso And Director
CEO / President 212 000
Value: $788.6K
Aug 19, 2020
Buy
Stock Options
A-Award
Foster Robert T
CEO,cso And Director
CEO / President 212 000
Value: $788.6K
Aug 19, 2020
Buy
Stock Options
A-Award
Lippa Arnold
Director
Director 30 000
Value: $111.6K
Aug 19, 2020
Buy
Stock Options
A-Award
Block Timothy M.
Director
Director 30 000
Value: $111.6K
Aug 19, 2020
Buy
Stock Options
A-Award
Adams Thomas Phd
Director
Director 30 000
Value: $111.6K
Aug 19, 2020
Buy
Stock Options
A-Award
Brancaccio John P
Director
Director 30 000
Value: $111.6K
Aug 19, 2020
Buy
Stock Options
A-Award
Jacob Gary S
Director
Director 30 000
Value: $111.6K
Aug 19, 2020
Buy
Stock Options
A-Award
Cavan John T
Chief Financial Officer
C-Suite Officer 160 000
Value: $595.2K
Aug 19, 2020
Buy
Stock Options
A-Award
Wijngaard Peter
Director
Director 30 000
Value: $111.6K
Jun 25, 2020
Buy
Stock Options
A-Award
Wijngaard Peter
Director
Director 30 000
Value: $81.9K
Jun 25, 2020
Buy
Stock Options
A-Award
Wijngaard Peter
Director
Director 30 000
Value: $81.9K
Jun 10, 2020
Buy
Common Stock
J-Other
Wijngaard Peter
Director 0
Value: $0
Jun 10, 2020
Buy
Common Stock
J-Other
Wijngaard Peter
Director 0
Value: $0
Apr 03, 2020
Buy
Stock Option
A-Award
Adams Thomas Phd
Director
Director 60 000
Value: $97.8K
Apr 03, 2020
Buy
Stock Options
A-Award
Lippa Arnold
Director
Director 60 000
Value: $97.8K
Apr 03, 2020
Buy
Stock Options
A-Award
Block Timothy M.
Director
Director 60 000
Value: $97.8K
Apr 03, 2020
Buy
Stock Options
A-Award
Lippa Arnold
Director
Director 60 000
Value: $97.8K
Apr 03, 2020
Buy
Stock Options
A-Award
Brancaccio John P
Director
Director 60 000
Value: $97.8K
Apr 03, 2020
Buy
Stock Options
A-Award
Foster Robert T
CEO And Cso
CEO / President 380 000
Value: $619.4K
Apr 03, 2020
Buy
Stock Options
A-Award
Jacob Gary S
Director
Director 60 000
Value: $97.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT HEPION PHARMACEUTICALS, INC.
Hepion Pharmaceuticals
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE